University of Sussex
Browse

File(s) under permanent embargo

Effect of varenicline on aspects of inhibitory control in smokers

journal contribution
posted on 2023-06-08, 21:49 authored by A J Austin, Dora Duka, Jennifer Rusted, A Jackson
RATIONALE: Varenicline, a partial agonist at a4ß2 nicotinic receptors (nAChRs) aids smoking cessation by reducing craving. Successful quitting may be associated with greater inhibitory control but the effectiveness of varenicline in this regard is unknown. OBJECTIVES: This study aimed to investigate the effect of varenicline on aspects of inhibitory control in smokers. METHODS: A double-blind, placebo-controlled study investigating the effect of varenicline 1 mg (or matched placebo) in satiated and abstinent smokers. Tests included Rapid Visual Information Processing (RVIP), Stop-Signal (SS), Prospective Memory (PM) and the Cambridge Gambling Task (CGT). RESULTS: Smoking enhanced RVIP accuracy and latency to respond. Varenicline did not alter RVIP performance, nor the effect of smoking, suggesting that these effects were unrelated to a4ß2 nAChRs. Smoking increased the number of errors during SS and increased the stop latency, indicating that smoking decreased inhibitory control. Varenicline partially mimicked this effect of smoking but also reduced the smoking-induced increase, indicating a role for a4ß2 nAChRs. Likewise, smoking increased the number of points bet following a win during CGT and varenicline blocked this effect. There was no effect of smoking or varenicline on PM target detection per se. However, smoking protected the target detection rate in the ongoing task when a concurrent intention was introduced. Varenicline improved response speed in both satiated and abstinent smokers. CONCLUSIONS: Some aspects of inhibitory control may be mediated by a4ß2-related mechanisms and blockade of smoking-induced disinhibition may contribute towards the action of varenicline as an aid to smoking cessation.

History

Publication status

  • Published

File Version

  • Published version

Journal

Psychopharmacology

ISSN

0033-3158

Publisher

Springer

Issue

18

Volume

231

Page range

3771-3785

Department affiliated with

  • Psychology Publications

Full text available

  • No

Peer reviewed?

  • Yes

Legacy Posted Date

2015-07-22

First Compliant Deposit (FCD) Date

2015-07-22

Usage metrics

    University of Sussex (Publications)

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC